RESUMO
To identify additional potential functions for the multi-PDZ domain containing protein Na+/H+ exchanger regulatory factor 2 (NHERF2), which is present in the apical domain of intestinal epithelial cells, proteomic studies of mouse jejunal villus epithelial cell brush border membrane vesicles compared wild-type to homozygous NHERF2 knockout FVB mice by a two-dimensional liquid chromatography-tandem mass spectrometry (LC-MS/MS)-iTRAQ approach. Jejunal architecture appeared normal in NHERF2 null in terms of villus length and crypt depth, Paneth cell number, and microvillus structure by electron microscopy. There was also no change in proliferative activity based on BrdU labeling. Four brush border membrane vesicles (BBMV) preparations from wild-type mouse jejunum were compared with four preparations from NHERF2 knockout mice. LC-MS/MS identified 450 proteins in both matched wild-type and NHERF2 null BBMV; 13 proteins were changed in two or more separate BBMV preparations (9 increased and 4 decreased in NHERF2 null mice), while an additional 92 proteins were changed in a single BBMV preparation (68 increased and 24 decreased in NHERF2 null mice). These proteins were categorized as 1) transport proteins (one increased and two decreased in NHERF2 null); 2) signaling molecules (2 increased in NHERF2 null); 3) cytoskeleton/junctional proteins (4 upregulated and 1 downregulated in NHERF2 null); and 4) metabolic proteins/intrinsic BB proteins) (2 upregulated and 1 downregulated in NHERF2 null). Immunoblotting of BBMV was used to validate or extend the findings, demonstrating increase in BBMV of NHERF2 null of MCT1, coronin 3, and ezrin. The proteome of the NHERF2 null mouse small intestinal BB demonstrates up- and downregulation of multiple transport proteins, signaling molecules, cytoskeletal proteins, tight junctional and adherens junction proteins, and proteins involved in metabolism, suggesting involvement of NHERF2 in multiple apical regulatory processes and interactions with luminal contents.
Assuntos
Jejuno/metabolismo , Fosfoproteínas/genética , Proteoma/metabolismo , Trocadores de Sódio-Hidrogênio/genética , Animais , Caderinas/metabolismo , Proliferação de Células , Cromatografia Líquida , Citoesqueleto/metabolismo , Regulação para Baixo , Imunofluorescência , Masculino , Camundongos , Camundongos Knockout , Microvilosidades/genética , Microvilosidades/metabolismo , Fosfoproteínas/metabolismo , Trocadores de Sódio-Hidrogênio/metabolismo , beta Catenina/metabolismoRESUMO
Na/H exchanger regulatory factor 1 (NHERF1) is a scaffold protein made up of two PDZ domains and an ERM binding domain. It is in the brush border of multiple epithelial cells where it modulates 1) Na absorption by regulating NHE3 complexes and cytoskeletal association, 2) Cl secretion through trafficking of CFTR, and 3) Na-coupled phosphate absorption through membrane retention of NaPi2a. To further understand the role of NHERF1 in regulation of small intestinal Na absorptive cell function, with emphasis on apical membrane transport regulation, quantitative proteomic analysis was performed on brush border membrane vesicles (BBMV) prepared from wild-type (WT) and homozygous NHERF1 knockout mouse jejunal villus Na absorptive cells. Jejunal architecture appeared normal in NHERF1 null; however, there was increased proliferative activity, as indicated by increased crypt BrdU staining. LC-MS/MS analysis using iTRAQ to compare WT and NHERF1 null BBMV identified 463 proteins present in both WT and NHERF1 null BBMV of simultaneously prepared and studied samples. Seventeen proteins had an altered amount of expression between WT and NHERF1 null in two or more separate preparations, and 149 total proteins were altered in at least one BBMV preparation. The classes of the majority of proteins altered included transport proteins, signaling and trafficking proteins, and proteins involved in proliferation and cell division. Affected proteins also included tight junction and adherens junction proteins, cytoskeletal proteins, as well as metabolic and BB digestive enzymes. Changes in abundance of several proteins were confirmed by immunoblotting [increased CEACAM1, decreased ezrin (p-ezrin), NHERF3, PLCß3, E-cadherin, p120, ß-catenin]. The changes in the jejunal BBMV proteome of NHERF1 null mice are consistent with a more complex role of NHERF1 than just forming signaling complexes and anchoring proteins to the apical membrane and include at least alterations in proteins involved in transport, signaling, and proliferation.
Assuntos
Jejuno/metabolismo , Fosfoproteínas/genética , Proteoma/análise , Trocadores de Sódio-Hidrogênio/genética , Vesículas Transportadoras/metabolismo , Animais , Caderinas/análise , Cromatografia por Troca Iônica , Feminino , Immunoblotting , Imuno-Histoquímica , Jejuno/citologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Microscopia Eletrônica , Microvilosidades/metabolismo , Microvilosidades/ultraestrutura , Fosfoproteínas/metabolismo , Proteômica/métodos , Trocadores de Sódio-Hidrogênio/metabolismo , Espectrometria de Massas em Tandem , beta Catenina/análiseRESUMO
The mean bulk magnetic susceptibility (x) and the intensity of remanent magnetization (J) of deep-sea sediments vary systematically, but in an opposite sense, for a distance of 600 kilometers downwind from the Azores. Beyond the distance both J and x diminish for at least another 600 kilometers. The dominant type of magnetic particle in the sediments is interpreted to be atmospherically transported volcanic dust.
RESUMO
Subcutaneous and intracerebral injections of calcitonin inhibited feeding in rats. The anorectic activity of calcitonin was destroyed by exposing the hormone to heat, trypsin, or hydrogen peroxide. Calcitonin did not produce a conditioned taste aversion to saccharin, and maximum inhibition of feeding occurred 4.5 to 8.3 hours after subcutaneous administration. It is concluded that calcitonin inhibits feeding by acting directly on the central nervous system.
Assuntos
Calcitonina/farmacologia , Comportamento Alimentar/efeitos dos fármacos , Animais , Encéfalo/efeitos dos fármacos , Calcitonina/administração & dosagem , Depressão Química , Diurese/efeitos dos fármacos , Relação Dose-Resposta a Droga , Injeções Intraventriculares , RatosRESUMO
Damage to the central and peripheral nervous system often produces lasting functional deficits. A major focus of neuroscience research has been to enhance functional restitution of the damaged nervous system and thereby produce recovery of behavioral or physiological processes. Promising procedures include surgical, physical, and chemical manipulations to reduce scar formation and minimize the disruption of support elements, administration of growth-stimulating substances, tissue grafts to bridge gaps in fiber pathways, and embryonic brain tissue grafts to provide new cells with the potential to generate fiber systems. Two elements are required for functional nervous system repair: (i) neurons with the capacity to extend processes must be present, and (ii) the regenerating neurites must find a continuous, unbroken pathway to appropriate targets through a supportive milieu.
Assuntos
Plasticidade Neuronal , Traumatismos do Sistema Nervoso , Fatores Etários , Anfíbios , Animais , Axônios/fisiologia , Membrana Celular/fisiologia , Sistema Nervoso Central/embriologia , Gangliosídeos/fisiologia , Glicoproteínas/fisiologia , Lampreias , Fatores de Crescimento Neural/fisiologia , Regeneração Nervosa , Sistemas Neurossecretores/fisiologia , Traumatismos dos Nervos Periféricos , Nervos Periféricos/fisiologia , Ratos , Retina/fisiologia , Traumatismos da Medula Espinal/fisiopatologiaRESUMO
In order to determine if brain tissue grafts can provide functional input to recipient central nervous system tissue, fetal rat dopamine-containg neurons were implanted adjacent to the caudate nucleus of adult recipients whose endogenous dopaminergic input had been destroyed. The grafts showed good survival and axonal outgrowth. Motor abnormalities, which had been induced by the destruction of the endogenous dopaminergic input to the caudate, were significantly reduced after grafting of the fetal brain tissue. These data suggest that such implants may be potentially useful in reversing deficits after circumscribed destruction of brain tissue.
Assuntos
Substância Negra/transplante , Animais , Corpo Estriado/fisiologia , Modelos Animais de Doenças , Sobrevivência de Enxerto , Humanos , Hidroxidopaminas/toxicidade , Masculino , Transtornos dos Movimentos/fisiopatologia , Doença de Parkinson/terapia , Ratos , Comportamento Estereotipado/fisiologia , Substância Negra/embriologia , Substância Negra/fisiologia , Transplante HomólogoRESUMO
Transplantation of embryonic substantia nigra into the adult rat brain decreases the motor asymmetry that is produced by dopamine receptor supersensitivity after a unilateral lesion of the substantia nigra. The authors report that this effect of transplantation is specific to grafts of substantia nigra. They also report that, in conjunction with the decrease in motor asymmetry, these grafts cause postsynaptic dopaminergic binding sites to return to normal density as measured by tritiated spiroperidol autoradiography. Thus, in animals with brain lesions, grafts of substantia nigra produce a long-term alteration in the functional status of host brain cell receptors that is associated with a reduction in the behavioral deficit.
Assuntos
Receptores Dopaminérgicos/metabolismo , Substância Negra/transplante , Animais , Apomorfina/farmacologia , Autorradiografia , Denervação , Dextroanfetamina/farmacologia , Atividade Motora/efeitos dos fármacos , Ratos , Ratos Endogâmicos , Espiperona/metabolismoRESUMO
One therapeutic approach to stroke is the transplantation of cells capable of trophic support, reinnervation, and/or regeneration. Previously, we have described the use of novel truncated isoforms of SV40 large T antigen to generate unique cell lines from several primary rodent tissue types. Here we describe the generation of two cell lines, RTC3 and RTC4, derived from primary mesencephalic tissue using a fragment of mutant T antigen, T155c (cDNA) expressed from the RSV promoter. Both lines expressed the glial markers vimentin and S100beta, but not the neuronal markers NeuN, MAP2, or beta-III-tubulin. A screen for secreted trophic factors revealed substantially elevated levels of platelet-derived growth factor (PDGF) in RTC4, but not RTC3 cells. When transplanted into rat cortex, RTC4 cells survived for at least 22 days and expressed PDGF. Because PDGF has been reported to reduce ischemic injury, we examined the protective functions of RTC4 cells in an animal model of stroke. RTC4 or RTC3 cells, or vehicle, were injected into rat cortex 15-20 min prior to a 60-min middle cerebral artery ligation. Forty-eight hours later, animals were sacrificed and the stroke volume was assessed by triphenyl-tetrazolium chloride (TTC) staining. Compared to vehicle or RTC3 cells, transplanted RTC4 cells significantly reduced stroke volume. Overall, we generated a cell line with glial properties that produces PDGF and reduces ischemic injury in a rat model of stroke.
Assuntos
Mesencéfalo/citologia , Acidente Vascular Cerebral/prevenção & controle , Animais , Morte Celular , Linhagem Celular Transformada , Sobrevivência Celular , Infarto Cerebral/induzido quimicamente , Infarto Cerebral/prevenção & controle , Modelos Animais de Doenças , Substâncias de Crescimento/metabolismo , Masculino , Mesencéfalo/transplante , Fenótipo , Fator de Crescimento Derivado de Plaquetas/metabolismo , Ratos , Ratos Sprague-DawleyRESUMO
Neuropsychiatric disorders are generally diagnosed based on a classification of behavioral and, in some cases, specific neurological deficits. The lack of distinct quantitative and qualitative biological descriptors at the anatomical and cellular level complicates the search for and understanding of the neurobiology of these disorders. The advent of microarray technology has enabled large-scale profiling of transcriptional activity, allowing a comprehensive characterization of transcriptional patterns relating to the pathophysiology of neuropsychiatric disorders. We review some of the unique methodological constraints related to the use of human postmortem brain tissue in addition to the generally applicable requirements for microarray experiments. Microarray studies undertaken in neuropsychiatric disorders such as schizophrenia and substance abuse by the use of postmortem brain tissue indicate that transcriptional changes relating to synaptic function and plasticity, cytoskeletal function, energy metabolism, oligodendrocytes, and distinct intracellular signaling pathways are generally present. These have been supported by microarray studies in experimental models, and have produced multiple avenues to be explored at the functional level. The quality and specificity of information obtained from human postmortem tissue is rapidly increasing with the maturation and refinement of array-related methodologies and analysis tools, and with the use of focused cell populations. The development of experimental models of gene regulation in these disorders will serve as the initial step towards a comprehensive genome-linked analysis of the brain and associated disorders, and help characterize the integration and coordinate regulation of complex functions within the CNS.
Assuntos
Análise de Sequência com Séries de Oligonucleotídeos , Esquizofrenia/genética , Transtornos Relacionados ao Uso de Substâncias/genética , Perfilação da Expressão Gênica , Humanos , Bainha de Mielina/metabolismo , RNA/metabolismo , Esquizofrenia/metabolismo , Transtornos Relacionados ao Uso de Substâncias/metabolismo , Sinapses/metabolismoRESUMO
This paper presents an hypothesis regarding the functions of striatal dopaminergic and glutamatergic neurotransmission. It is suggested that the principal functional role of dopaminergic neurotransmission is to regulate the efficacy of cortico-striatal and cortico-accumbens neurotransmission. Increased activity at dopamine-mediated synapses is suggested to interact with neurotransmission at adjacent cortically derived glutamate-mediated synapses, facilitating communication from the cerebral cortex, and thereby causing behavioral stimulation. Decreased activity at dopaminergic synapses, as produced by neuroleptic drugs, causes changes in the activation of cortically derived synapses in the corpus striatum and nucleus accumbens which result in behavioral sedation and decreased activity. This hypothesis suggests that activity at dopaminergic synapses produces behavioral effects only insofar as these changes modulate cortico-striatal (or cortico-accumbens) activity, and further, that the manifestations of activity in cortico-striatal systems are modulated by activity at dopaminergic synapses. It is further suggested that when neuroleptics are administered chronically, adjustments in the efficacy of cortico-striatal neurotransmission are responsible for the antipsychotic effect of neuroleptic drugs.
Assuntos
Antipsicóticos/farmacologia , Estimulantes do Sistema Nervoso Central/farmacologia , Glutamatos/fisiologia , Animais , Dopamina/fisiologia , Humanos , Modelos NeurológicosRESUMO
Using a rotational behavior animal model, it has been found that embryonic substantia nigra (SN) can be homologously transplanted to the brain lateral ventricles to reverse the effects of SN lesions. These grafts were found to decrease the lesion-induced rotational behavior that was provoked either by apomorphine or amphetamine. This effect was not duplicated by grafts of other embryonic brain regions. The SN grafts produced a dopaminergic reinnervation of the dorsomedial striatum that appeared to be responsible for the behavioral amelioration. Long-term studies demonstrated that behavioral efficacy and survival continued for at least 6 months to 1 1/2 years. The catecholaminergic "chromaffin" cells of the adrenal medulla possess a remarkable ability to change morphologically and biochemically in response to their environmental hormonal milieu. This plasticity was exploited by transplanting adrenal medulla to the rat brain to reverse the effects of SN lesions. This tissue changed biochemically by producing large amounts of dopamine, and morphologically, by extending coarse fiber processes. Although these grafts appeared to secrete catecholamines, they did not reinnervate the striatum. Rotational behavior was reduced by these grafts, apparently as a consequence of the catecholamine secretion. When adrenal chromaffin tissue was obtained from 1- or 2-year-old donors, however, lesion-induced rotational behavior was not reduced. It is suggested that adrenal chromaffin cell grafts from young donors possess a biochemical plasticity that is the basis for the behavioral effect, but that this plasticity is lost with maturity of the tissue. An important issue for future applications of these procedures is the immunological privilege of the brain lateral ventricles. We found that both embryonic brain tissue and adult adrenal medulla "allografts" from Brown Norway rat donors consistently survived for at least 6 months in the ventricles of Fisher 344-strain rat hosts. These strains differ in major histocompatibility antigens and, as expected, Fisher 344 rats rapidly rejected Brown Norway skin grafts. Skin graft survival times were not influenced by the presence of established brain grafts, nor did brain grafts elicit systemic humoral immunity. Conversely, however, independent elicitation of systemic immunity by skin grafting resulted in the rejection of long-established brain grafts concomitant with rejection of the skin grafts. Rotational behavior in Fisher 344 hosts was reduced by brain grafts from Brown Norway donors; yet, after rotation had been reduced it could be brought back to baseline levels through systemic immunization and associated brain graft rejection.(ABSTRACT TRUNCATED AT 400 WORDS)
Assuntos
Medula Suprarrenal/transplante , Ventrículos Cerebrais/cirurgia , Regeneração Nervosa , Substância Negra/transplante , Medula Suprarrenal/imunologia , Animais , Apomorfina/farmacologia , Diferenciação Celular , Ventrículos Cerebrais/imunologia , Ventrículos Cerebrais/fisiologia , Corpo Estriado/fisiologia , Olho/embriologia , Olho/transplante , Sobrevivência de Enxerto , Histocompatibilidade , Atividade Motora/efeitos dos fármacos , Atividade Motora/fisiologia , Ratos , Ratos Endogâmicos BN , Ratos Endogâmicos F344 , Retina/embriologia , Retina/transplante , Substância Negra/embriologia , Substância Negra/imunologia , Transplante HomólogoRESUMO
Short-term haloperidol treatment decreases the stimulant effects of drugs with dopaminelike actions, while withdrawal from long-term haloperidol treatment enhances the effects of such drugs. In the present study, we have shown that withdrawal from long-term haloperidol treatment decreases or eliminates the tendency for imidazole-4-acetic acid, a GABA agonist, to decrease the locomotor activity of mice. Acute haloperidol treatment did not duplicate these effects. It is suggested that chronic administration of haloperidol causes changes in a variety of systems in the brain, and that the GABA system in particular is profoundly altered by such treatment.
Assuntos
Comportamento Animal/efeitos dos fármacos , Haloperidol/farmacologia , Imidazóis/farmacologia , Ácido gama-Aminobutírico/metabolismo , Animais , Relação Dose-Resposta a Droga , Feminino , Camundongos , Atividade Motora/efeitos dos fármacos , Receptores Dopaminérgicos/efeitos dos fármacos , Receptores de Neurotransmissores/efeitos dos fármacosRESUMO
The literature on the neuropathology of bipolar disorder (BD) is reviewed. Postmortem findings in the areas of pathomorphology, signal transduction, neuropeptides, neurotransmitters, cell adhesion molecules, and synaptic proteins are considered. Decreased glial numbers and density in both BD and major depressive disorder (MDD) have been reported, whereas cortical neuron counts were not different in BD (in Brodmann's areas [BAs] 9 and 24). In contrast, MDD patients showed reductions in neuronal size and density (BA 9, BA 47). There are a number of findings of alterations in neuropeptides and monoamines in BD brains. Norepinephrine turnover was increased in several cortical regions and thalamus, whereas the serotonin metabolite, 5-hydroxyindoleacetic acid, and the serotonin transporter were reduced in the cortex. Several reports further implicated both cyclic adenosine monophosphate and phosphatidylinositol (PI) cascade abnormalities. G protein concentrations and activity increases were found in the occipital, prefrontal, and temporal cortices in BD. In the PI signal cascade, alterations in PKC activity were found in the prefrontal cortex. In the occipital cortex, PI hydrolysis was decreased. Two isoforms of the neural cell adhesion molecules were increased in the hippocampus of BD, whereas the synaptic protein marker, synaptophysin, was not changed. The findings of glial reduction, excess signal activity, neuropeptide abnormalities, and monoamine alterations suggest distinct imbalances in neurochemical regulation. Possible alterations in pathways involving ascending projections from the brain stem are considered. Larger numbers of BD brains are needed to further refine the conceptual models that have been proposed, and to develop coherent models of the pathophysiology of BD.
Assuntos
Transtorno Bipolar/metabolismo , Transtorno Bipolar/patologia , Encéfalo/metabolismo , Encéfalo/patologia , Autopsia , Química Encefálica , Moléculas de Adesão Celular/metabolismo , Humanos , Proteínas do Tecido Nervoso/metabolismo , Neuroglia/patologia , Neurônios/patologia , Transdução de SinaisRESUMO
BACKGROUND: The purposes of the present study were to attempt to replicate a previous finding of increased cerebrospinal fluid (CSF) neuronal cell adhesion molecule (N-CAM) in schizophrenia, and to assess whether the increases could be related to medication, clinical state effects, or brain structural measures. METHODS: CSF N-CAM was measured by the Western blot technique in 45 DSM-III-R diagnosed male schizophrenic patients both on and off haloperidol treatment and in 20 healthy male control subjects. RESULTS: CSF N-CAM was significantly increased in schizophrenic patients, with no overlap in the ranges, when compared to controls. There were no significant effects of medication or exacerbation on CSF N-CAM. No associations with measures of brain structure were found. CONCLUSIONS: Because N-CAM levels were not shown to be different on and off treatment or in exacerbated versus nonexacerbated patients, the higher levels seen in schizophrenic patients may be inherent to the disorder and possibly related to neurodevelopment.
Assuntos
Moléculas de Adesão de Célula Nervosa/líquido cefalorraquidiano , Esquizofrenia/líquido cefalorraquidiano , Adulto , Atrofia , Western Blotting , Encéfalo/patologia , Proteínas do Líquido Cefalorraquidiano/metabolismo , Humanos , Masculino , Escalas de Graduação Psiquiátrica , Esquizofrenia/patologia , Psicologia do Esquizofrênico , Tomografia Computadorizada por Raios XRESUMO
From a review of the clinical literature, the authors determined that the medical symptoms of neuroleptic withdrawal occurred more frequently with neuroleptics having potent anticholinergic effects than with those having weak anticholinergic actions. When antiparkinsonian agents were not simultaneously withdrawn, there was a striking difference between these two categories of neuroleptics. Experiments with mice showed that withdrawal of haloperidol, a neuroleptic with weak anticholinergic effects, produced subsensitivity (depression of locomotor activity and seizure thresholds) to the cholinergic effects of physostigmine. These findings support the theory that the medical side effects of neuroleptic withdrawal are due to rebound cholinergic hypersensitivity associated with the anticholinergic actions of these drugs, rather than being related to their dopamine-blocking activity.
Assuntos
Antipsicóticos/efeitos adversos , Receptores Colinérgicos/efeitos dos fármacos , Síndrome de Abstinência a Substâncias/etiologia , Animais , Antiparkinsonianos/efeitos adversos , Relação Dose-Resposta a Droga , Feminino , Haloperidol/efeitos adversos , Humanos , Camundongos , Fisostigmina/farmacologia , Receptores Muscarínicos/efeitos dos fármacos , Convulsões/induzido quimicamenteRESUMO
Spontaneous eye-blinking, a possible measure of central dopaminergic activity, was studied in 55 drug-free chronic schizophrenic patients subdivided by cerebral ventricular size. Blink rates were higher in schizophrenic patients than in normal control subjects, regardless of cerebral ventricle size. Neuroleptics lowered blink rates in patients with normal ventricles but did not affect blink rates in patients with large ventricles. Insofar as blinking is a dopaminergic parameter, these findings suggest that the dopamine hypothesis of schizophrenia is most relevant in patients with normal ventricles.
Assuntos
Piscadela , Ventrículos Cerebrais/anatomia & histologia , Esquizofrenia/fisiopatologia , Adulto , Antropometria , Antipsicóticos/farmacologia , Antipsicóticos/uso terapêutico , Piscadela/efeitos dos fármacos , Doença Crônica , Dopamina/fisiologia , Relação Dose-Resposta a Droga , Feminino , Humanos , Hidrocefalia/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Esquizofrenia/diagnóstico , Esquizofrenia/tratamento farmacológico , Tomografia Computadorizada por Raios XRESUMO
Phencyclidine (PCP) and amphetamine (AMP) can induce psychotic syndromes in humans, whereas administration of these drugs to mice results in behavioral activation that is influenced by genetic factors. Quantitative trait loci (QTL) underlying genetic differences in response to PCP and AMP in mice were provisionally identified by correlating allelic variation at known marker loci in the BXD series of recombinant inbred (RI) mice and its progenitors (C57BL/6J and DBA/2J inbred strains) with the locomotor response of each strain to PCP and AMP. Total distance traveled for individual mice from each of the 26 BXD RI and two progenitor strains was measured after injections of normal saline and 7.5 mg/kg i.p. injection of PCP. This procedure was repeated after 1 week, using 5.0 mg/kg of AMP, instead of PCP. Markers significantly (p < .01) correlated with response to PCP map to murine chromosomes 1, 14, and 15. Response to amphetamine was correlated with markers mapping to chromosomes 4, 5, 6, 8, 14, and 18. Identification of the QTL underlying PCP-induced and AMP-induced behavior in mice may provide clues into the complicated genetics of psychosis in humans.
Assuntos
Anfetamina/farmacologia , Estimulantes do Sistema Nervoso Central/farmacologia , Antagonistas de Aminoácidos Excitatórios/farmacologia , Atividade Motora/efeitos dos fármacos , Atividade Motora/genética , Fenciclidina/farmacologia , Animais , Feminino , Marcadores Genéticos , Camundongos , Camundongos EndogâmicosRESUMO
Rats were treated with the neurotoxin iminodipropionitrile (IDPN), which causes an irreversible movement disorder accompanied by axonal damage similar to that seen in vitamin E deficiency. Animals that received 2 g/kg vitamin E concurrently with 100 mg/kg IDPN for 10 days demonstrated a significantly reduced severity of IDPN-induced dyskinesia (as measured by vertical head movements) compared to animals that received IDPN alone. When animals were treated with 100 mg/kg IDPN for 10 days and then given either 2 g/kg vitamin E or an equivalent volume of sesame oil for 7 days, vitamin E produced a significant reduction in the severity of IDPN-induced dyskinesia. In both experiments, locomotor activity was unchanged by vitamin E. These data suggest a possible involvement of free radical formation in the neurotoxicity of IDPN.
Assuntos
Discinesia Induzida por Medicamentos/tratamento farmacológico , Nitrilas/antagonistas & inibidores , Vitamina E/uso terapêutico , Animais , Modelos Animais de Doenças , Discinesia Induzida por Medicamentos/fisiopatologia , Masculino , Ratos , Ratos EndogâmicosRESUMO
Transforming growth factor beta s (TGF beta s) are potent immunosuppressive molecules released in the brain after injury. We hypothesized that TGF beta levels in cerebrospinal fluid (CSF) of schizophrenic patients would be altered because TGF beta can influence neural cell adhesion molecule (N-CAM) expression in vitro. The levels of TGF beta 1 and beta 2 in CSF of patients with schizophrenia and normal controls measured by ELISA showed no differences. There was evidence that the stability of TGF beta in CSF may be altered in schizophrenia. For a limited sample, TGF beta 1 and N-CAM concentrations were significantly correlated in normal patients (r = 0.98) but not in schizophrenics. The results do not support an active neurodegeneration or anti-inflammatory response in the central nervous system, which is reflected in the CSF of chronic schizophrenics.
Assuntos
Esquizofrenia/líquido cefalorraquidiano , Fator de Crescimento Transformador beta/líquido cefalorraquidiano , Adulto , Doença Crônica , Feminino , Humanos , Masculino , Moléculas de Adesão de Célula Nervosa/biossíntese , Fator de Crescimento Transformador beta/biossínteseRESUMO
A variety of neuroleptics were compared for their ability to block phencyclidine (PCP)-induced behavioral stimulation in mice. Methiothepin, fluphenazine, trifluoperazine, and chlorpromazine were highly effective in blocking phencyclidine-induced stimulation at doses that did not decrease spontaneous behavioral activity. Clozapine, thioridazine and haloperidol were moderately effective, while sulpiride, molindone, and pimozide were completely ineffective. The effectiveness of the drugs was found to be correlated with their ability to block tryptamine-induced seizures and with several other measures of antidopaminergic and antiserotonergic potency. it is concluded that a combination of antidopaminergic and antiserotonergic activity is important for blocking the stimulating effects of phencyclidine.